Yoshihiro Yonekawa, MD Mass Eye & Ear / Boston Children’s RETINA Roundup Co-Editor The age-related macular degeneration (AMD) session at Retina Society is always jam-packed. Patients with AMD comprise a…
Hossein Nazari Khanamiri, MD Ophthalmology Resident UTMB Ophthalmology and Visual Sciences The late breaking session is reserved for high-profile and potentially industry-moving clinical trial data that becomes available often after…
The use of anti-VEGF therapy has revolutionized the treatment of wet AMD, such that most patients can now maintain functional vision for their lifetimes. However, the need for frequent injections…
Nitish Mehta, MD Ophthalmology Resident New York University Yasha Modi, MD Assistant Professor of Ophthalmology New York University Yesterday we reported on the favorable Phase II results from Genentech’s BOULEVARD…
Nitish Mehta, MD Ophthalmology Resident New York University Yasha Modi, MD Assistant Professor of Ophthalmology New York University Many companies are working to fill unmet needs in the treatment of…
Rachel Huckfeldt, MD, PhD Inherited Retinal Diseases Service Mass Eye and Ear / Harvard Medical School Earlier this week on Tuesday December 19th, the FDA announced its approval of Luxturna…
Eric Nudleman, MD, PhD Shiley Eye Institute, UCSD Editor, RETINA Roundup Although anti-VEGF therapy has revolutionized the management of retinal vascular diseases, there has been significant effort in recent years…
Kevin Chen, MD Vitreoretinal Surgery Fellow University of California San Diego Dr. Raj Maturi reported on data from the highly anticipated DRCR.net Protocol U. This study is a multicenter randomized…
